The Big Role mPOCT Device Plays in SARS-CoV-2 Detection

---

In contrary to the traditional testing usually conducted in laboratories, point-of-care testing (POCT) refers to the medical diagnostic testing done near the point of care. POCT enables the decentralization of some of the diagnostic tests while bringing the testing and the diagnoses closer to the patient. The prompt availability of the results makes healthcare professionals reach immediate and informed decisions about patient care. Consequently, medical practitioners can initiate testing anywhere, anytime, and patients do not have to wait long hours even days to learn the result. That’s how POCT, being a mutually beneficial medical testing method, boosts efficiency while improving patients’ experience.

Molecular POCT (mPOCT) is a term that combines both POCT and molecular testing, which refers to the detection of blood, tissue, or other body fluid to check for certain genes of pathogens that may be a sign of a condition or disease. The principle behind molecular testing is multiplying the amount of DNA or RNA segment within a specific specimen by millions of times before analyzing it. Point-of-care testing technology is advancing at a fast pace, making it easier to narrow complex testing platforms into point-of-care testing devices. Molecular testing far surpasses the accuracy of other traditional testing, while POCT is superior to the traditional one for efficiency. Therefore, it is safe to say that mPOCT combines the strengths of both molecular testing and point-of-care testing.

 

The Main Features of mPOCT

mPOCT provides distinct benefits both to healthcare institutions and patients. Some of the most prominent reasons for the growing demand for mPOCT include:

• Quicker diagnosis

Molecular POCT is fast, easy testing with higher efficiency if compared to traditional equipment. In addition, POCT tests are becoming increasingly accurate helping health professionals make better and more effective decisions in a shorter timeframe.

• Easily portable for more scenarios

Thanks to the portability of the relevant equipment, such as iPonatic® III – Portable Molecular Workstation developed by Sansure, mPOCT plays an increasingly vital role in various series of settings, including hospitals, urgent care clinics, general practitioner’s offices, retail clinics, airports, customs, and more.

• Better experience

mPOCT facilitates the result delivered within a short time, so that the patients do not have to visit hospital and wait for a few days to learn the result. From the perspective of hospitals, mPOCT shortens the length of their patients’ hospital stay, and cuts the care costs when patients can discharge from the hospitals faster than before.

 

Key Features and Strengths

iPonatic® III – Portable Molecular Workstation is a new member of Sansure’s iPonatic series, which will open up a new “digital and intelligent” era of molecular diagnostics. Aiming at innovating traditional diagnostic mode and assisting precision diagnosis, iPonatic III promises a quick, convenient diagnosis experience for a clinical emergency, health management, biological emergency, and other various applications.

As a top-of-the-line mPOCT detection device, iPonatic III also has the following strengths:

• Easily Operated

As a highly developed portable molecular detection workstation, Sansure’s iPonatic III integrates one-tube fast release technology and rapid PCR amplification technology to further enhance sample processing, nucleic acid extraction and purification, PCR amplification, fluorescence detection and result processing modules. But with so many functions, iPonatic III is still an easily operated and managed machine, good to be handled by both medical experts and trained operators.

• Ultra-fast Amplification System

This system has a fully automated rapid testing process with a “sample-in-result-out” feature which makes test results available in only 8-45 minutes.

• Pre-packaged Kits

With its pre-packaged kits that significantly shorten the hands-on time and reduce the chance of contamination, iPonatic III is the answer to the issues caused by recent COVID-19 yet remain unsolved due to delays associated with centralized laboratory PCR testing.

Meanwhile, paired with diagnostic kits like Novel Coronavirus (2019-nCoV) Nucleic Acid Diagnostic Kit (S3102E)  that uses one-tube fast release technology, iPonatic III can even be more accurate and efficient, with its LOD reaching 200 copies/mL. 

• Always Ready for Use

The product can test physical items at any time. Benefiting from flexible wireless connection capability, up to 8 units can be wirelessly connected to carry out inspection as soon as the arrival of samples.

 

Sansure’s State-of-the-art POCT Products

Sansure has maintained its mission of providing innovative diagnostics for all. Innovation is not just a buzzword for Sansure, where everything, from our great team of researchers to our product quality control, aims at delivering our customers the best diagnostic quality and reliability.

Our innovative Sansure iPonatic Ⅲ and over 500 diagnostic products have already enabled healthcare professionals worldwide to provide better patient care and save more lives, and we will continue to offer more optimal healthcare for the well-being of humanity.